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Abstract
Several candidate HIV vaccines aim to induce virus-specific cellular immunity particularly in the genital tract, typically the
initial site of HIV acquisition. However, standardized and sensitive methods for evaluating HIV-specific immune responses at
the genital level are lacking. Therefore we evaluated real-time quantitative PCR (qPCR) as a potential platform to measure
these responses. b-Actin and GAPDH were identified as the most stable housekeeping reference genes in peripheral blood
mononuclear cells (PBMCs) and cervical mononuclear cells (CMCs) respectively and were used for normalizing transcript
mRNA expression. HIV-specific cellular T cell immune responses to a pool of optimized CD8+ HIV epitopes (HIV epitope
pool) and Staphylococcal enterotoxin B (SEB) superantigen control were assayed in HIV infected PBMC by qPCR, with
parallel assessment of cytokine protein production. Peak HIV-specific mRNA expression of IFNc, IL-2 and TNFa occurred after
3, 5 and 12 hours respectively. PBMCs were titrated to cervical appropriate cell numbers to determine minimum required
assay input cell numbers; qPCR retained sensitivity with input of at least 2.5610
4 PBMCs. This optimized qPCR assay was
then used to assess HIV-specific cellular T cell responses in cytobrush-derived cervical T cells from HIV positive individuals.
SEB induced IFNc mRNA transcription was detected in CMCs and correlated positively with IFNc protein production.
However, qPCR was unable to detect HIV-induced cytokine mRNA production in the cervix of HIV-infected women despite
robust detection of gene induction in PBMCs. In conclusion, although qPCR can be used to measure ex vivo cellular immune
responses to HIV in blood, HIV-specific responses in the cervix may fall below the threshold of qPCR detection. Nonetheless,
this platform may have a potential role in measuring mitogen-induced immune responses in the genital tract.
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Introduction
Globally, 33 million people are now infected with the Human
Immunodeficiency Virus (HIV) [1] and more than 90% of new
infections occur across the mucosal lining of the genital or
gastrointestinal tract [2]. Women now account for most new HIV
infections [2,3,4,5], with acquisition usually occurring across the
cervico-vaginal mucosa during sex [2]. HIV-specific T cell
responses are an important component of the host immune
response against HIV, and have been described in the genital
mucosa of both HIV-infected and exposed but uninfected women
[6,7,8,9,10]. However, the role of genital HIV-specific cellular
immunity in HIV susceptibility and transmission remains poorly
defined, in part, due to methodological limitations [5,11].
Currently, several candidate HIV vaccines aim to induce virus-
specific cellular immune cytotoxic T lymphocyte (CTL) protection
[12,13,14,15]. Therefore, the ability to monitor HIV-specific
cellular immune responses in the female genital tract will be
important in monitoring and evaluating these HIV vaccines, and
may help to characterize the mucosal pathogenesis of HIV
transmission and susceptibility. Unfortunately, conventional cel-
lular immune assay platforms lack the sensitivity to measure these
mucosal responses in a reliable and reproducible way [16]. This is
due in large part to the low cell numbers obtained from standard
sampling techniques such as the cervical cytobrush or cervico-
vaginal lavage [6,8,9,10]. In vitro expansion of cervical cells to
overcome these limitations is possible, despite the issue of potential
fungal/bacterial contamination when cervical lymphocytes are
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13077maintained in long-term culture [9]. However, cervical cell
expansion precludes the assessment of ex vivo mucosal immune
response frequency, and the preferential expansion of certain
memory subsets using this technique means that the repertoire and
memory phenotype of cervical cells obtained via expansion may
not reflect in vivo mucosal T cell populations [11,17]. In addition,
assay platforms such as ELISPOT, chromium (Cr51) lysis and
proliferation (CFSE dilution or H3-thymidine uptake) have a
limited capacity to measure multiple immune functions. More
recently, multi-parameter flow cytometry assays in peripheral
blood mononuclear cells (PBMC) from HIV infected patients have
demonstrated that the breadth and quality of immune responses
appear more important than the quantity of responses in HIV
control [18]. Therefore relying on measurements of narrowly
defined HIV-specific immune responses might overlook the
spectrum of responses needed for efficient HIV control. However,
the recovery of few cervical mononuclear cells (CMCs) may still
challenge the feasibility of flow cytometry in measuring HIV-
specific genital tract immune responses [8].
Quantitative Real-Time PCR (qPCR) is a molecular technique
that might be adapted to overcome several of these obstacles. The
technique is highly sensitive [19,20], and in theory could
simultaneously assay the induction of multiple immune genes in
response to antigenic stimulation despite low sample cellular input.
qPCR has previously been utilized to measure basal cytokine
mRNA transcript levels in unstimulated cervical cells obtained by
cytobrush sampling [21,22], as well as in clonally expanded
PBMCs [20]. In addition, qPCR has frequently been used to assay
systemic antigen-specific immune responses in blood [19,20,23].
However, there are no published reports using this platform to
evaluate genital mucosal immune responses. We therefore adapted
the qPCR assay to define the optimal kinetics for HIV-specific
mRNA gene induction, evaluate qPCRs suitability to measure
these immune responses using cervical-appropriate reduced cell
numbers in a PBMC model, and compared our gene expression
results with conventional protein measurement assays. This
optimized qPCR assay was then used to assess HIV-specific
cellular T cell responses in cervical cytobrush-derived T cells from
HIV positive individuals.
Results
Selection of housekeeping genes
Reliable comparisons of gene expression between samples
require the normalization of input amounts, reverse transcription
and amplification reaction efficiencies. PBMCs and CMCs from 5
HIV infected individuals were incubated for 6 hours in R10
medium alone, HIV epitope pool, or SEB, and mRNA was
evaluated for the expression of the commonly-used housekeeping
genes including b-actin, B2M, GAPDH, HPRT and TBP [24,25].
Housekeeping gene expression stability across different tissues and
treatments was evaluated using the NormFinder analysis algorithm
which identified b -actin as the most stable HK gene in PBMCs
(stability value, 1622.17), while GAPDH was the most stable in
CMCs (stability value, 104.92). In PBMCs, the top 4 housekeeping
genes appeared to have a narrower spread in stability values
(range, 254.6 stability units) suggesting their stability their
expression remains constant in this cell type. However in CMCs,
GAPDH housekeeping gene emerged as the most stable gene with
no closely comparable housekeeping gene among the top 4
evaluated genes (range, 433.8 stability units). This finding
emphasizes the need to validate candidate housekeeping genes in
each sample source of interests. In both cell types, B2M gene was
the least stable. Table 1 summarises the ranking of HK genes from
the most to least stable. GAPDH and b-actin genes were selected
as our respective reference HK gene for normalization of cytokine
gene induction in CMC and PBMC cell types respectively.
Time course of HIV-specific mRNA induction and
cytokine release
To characterize virus-specific cellular T cell cytokine induction
kinetics, one million PBMCs from 4 HIV positive individuals were
stimulated with the predefined HIV CD8+ peptide epitope pool
for 12 hours; and ex vivo cultured cells were harvested at hourly
intervals for the first six hours and then once every two hours up to
12 hours. At this point the experiment was terminated since our
goal was to mimic the time course of cervical T cell assays, and in
our experience these may become contaminated in the context of
more prolonged incubation. mRNA and protein levels of IFNc,
TNFa and IL-2 were quantified in parallel. Cytokine mRNA and
protein kinetics were defined in PBMCs because of abundant cell
yields in this compartment.
IFNc was the most abundantly induced cytokine mRNA in all
PBMC stimulation conditions, followed by TNFa and IL-2
respectively. Median HIV-specific mRNA induction profiles
differed for each cytokine (Figure 1): IFNc peaked after 3 hours
of stimulation (fold induction 7.8) and IL-2 peaked after 5 hours
(fold induction 3.9). TNFa displayed a bimodal induction profile
with peaks, with the first mRNA induction peak occurring after 5–
6 hours (fold induction 3.0–3.3 fold) and the second after 12 hours
(fold induction 3.7). In contrast, supernatant protein levels of both
IFNc and TNFa increased steadily throughout the 12-hour
experimental period. No IL-2 protein was detected in cell
supernatants despite early mRNA induction.
Based on the above optimal cytokine kinetics, we selected to
incubate PBMCs and CMCs with HIV epitope pool for 6 hours.
This secondary optimal time point would allow for maximal
measurement of all cytokine gene induction and protein
production simultaneously.
Input cell numbers and measurement of cellular T cell
responses by qPCR
We next examined the ability of the qPCR assay platform to
detect HIV-specific cellular T cell responses in the context of
limited input cell numbers. Five chronically HIV-infected,
antiretroviral therapy-naı ¨ve participants with .350 CD4+ T cell
counts/mm
3 were randomly selected for these assays. All
Table 1. NormFinder rankings of candidate reference
housekeeping genes.
Rank CMC Stability value PBMC Stability value
1 GAPDH 104.9 b-Actin 1622.2
2 b-Actin 538.7 HPRT 1833.8
3 HPRT 574.6 TBP 1859.2
4 TBP 588.1 GAPDH 1876.8
5 B2M 3563.8 B2M 6997.3
b-2-Microglobulin (B2M); TATA box binding protein (TBP); Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH); human hypoxanthine
phosphoribosyltransferase (HPRT).
Genes are ranked from the most stable (1) to the least stable (5) according to
Norm-Finder gene-stability analysis algorithms. Housekeeping gene stability
was evaluated by comparing between 5 different HIV+ PBMC or CMC samples
and within an individual treated with either Negative control (R10 media,) HIV
antigen (HIV epitope pool) or positive control (SEB).
doi:10.1371/journal.pone.0013077.t001
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with an input cell number of 1610
6 PBMC/well. PBMCs were
plated at various concentrations (1610
6,1 610
5, 7.5610
4,
5.0610
4, 2.5610
4 and 1610
4 input cells/experiment) to model
expected ranges of cervical cell yields from cytobrush sampling,
incubated for 6 hours with R10 medium alone, SEB or the
predefined HIV epitope pool, and IFNc mRNA induction was
quantified by qPCR. Robust detection of HIV-specific IFNc
mRNA was seen across the full range of input cell numbers
(Figure 2a), with median HIV-specific mRNA induction levels
ranging from 4.2 fold (at 1610
6 input PBMCs) to 3.2 fold (with
1610
4 input PBMCs). Likewise, SEB-induced IFNc mRNA
induction levels remained constant across higher input cell
numbers, from 91.6 fold (at 1610
6 input PBMCs) to 73.7 fold
(at 2.5610
4 input PBMCs). However, SEB-induced IFNc
induction dropped off rapidly when less than 2.5610
4 input
cells/experiment were utilized, to just 6.0 fold above background
(Figure 2b), but was still higher than HIV antigen specific
induction levels at the same cell concentration. These findings
suggest that even at low numbers of input cells, modeled after
cervical cytobrush cell yields, qPCR is capable of detecting both
antigen and superantigen induced cytokine mRNA.
Evaluation of HIV-specific cervical cell immune responses
using qPCR
Having established optimal cytokine kinetics and cell number
sensitivity in PBMC, we next evaluated the ability of the qPCR
platform to measure ex vivo cervical HIV-specific immune
responses. Cervical cytobrushes and PBMCs were collected from
13 HIV-infected women in whom robust HIV-specific IFNc T cell
responses had been detected in blood with an input number of
1610
6 PBMC/well. Cytokine gene induction was assayed by
qPCR after 6 hours of incubation with media alone, SEB or HIV
epitope pool, and cytokine protein levels in supernatant were
assayed in parallel by M-ELISA.
Figure 1. Comparison of the cytokine kinetics of HIV-specific mRNA and protein induction. 1610
6 peripheral blood mononuclear cell
samples from 4 HIV infected individuals were incubated with HIV CD8+ T cell HIV optimized epitope antigen e (HIV epitope pool) and mRNA and
protein induction assayed via qPCR and CBA respectively. Bars represent median values with lines showing interquartile ranges measuring HIV-
specific IFNc (a), TNFa (b) and IL-2 (c) mRNA and protein induction kinetics are shown. Background levels of protein have been subtracted from
reported values above.
doi:10.1371/journal.pone.0013077.g001
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(p=0.042) but not IFNc or TNFa (IFNc, p=0.138; TNFa,
p=0.144; Wilcoxon Signed Ranks test) was observed compared to
medium alone in CMCs. Overall however, median HIV-specific
induction in CMCs for all genes remained at 1.0 fold for all cytokines
(Figure 3) suggesting that qPCR was unable to detect any HIV-
specific immune responses in the genital tract. Nonetheless, robust
detection of HIV-specific cellular T cell responses was observed in
PBMCs from the same participants (median fold induction; IFNc,
6.3; TNFa, 2.33; IL-2, 1.3; see Figure 3). CMC incubation with SEB
significantly induced mRNA expression of IFNc above background
(median 5.0 fold, p=0.012), TNFa (median 1.0, p=0.043) and IL-2
(median 1.9 fold, p=0.017) as evaluated using the Wilcoxon Signed
Ranks test(Figure4). In addition, SEB-induced cervical IFNcmRNA
expression was strongly associated with supernatant cytokine levels
measured by multiplex ELISA (Spearman’s rho =0.780, p=0.005;
Figure 2. Effect of blood mononuclear cell input number on
qPCR assay. A box and whiskers plot showing peripheral blood
mononuclear cell samples from 5 HIV infected subjects which were
plated at varying concentrations ranging from 1610
6 to 1610
4 cells/
experiment and treated with R10 media, HIV epitope pool antigen or
SEB positive control for 6 hours and IFNc mRNA fold expression assayed
using qPCR. Horizontal lines represent median values. (a) HIV-specific
response did not significantly decrease when cell numbers decreased
from 1610
6 to 1610
4 cells/experiment. (b) However, the magnitude of
SEB induced IFNc mRNA induction significantly decreased when less
than 2.5610
4 cells/experiment were used.
doi:10.1371/journal.pone.0013077.g002
Figure 3. HIV-specific cytokine gene induction in cervical and
blood mononuclear cells from HIV infected participants. (a)
IFNc, (b) TNFa and (c) IL-2 mRNA induction in cervical mononuclear cells
(CMCs) and peripheral blood mononuclear cells (PBMCs) from 13 HIV
infected women following incubation with HIV pool. Horizontal lines
represent median values. The qPCR assay readily detected HIV-specific
cytokine immune responses in PBMCs but was unable to do so in CMCs.
doi:10.1371/journal.pone.0013077.g003
qPCR: Assay Cervical Responses
PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13077Figure 5) but this was not the case for IL-2 or TNFa levels. In
PBMCs, the qPCR platform readily detected SEB-induced cytokine
expression above background (IFNc,1 4 8 . 8f o l d ,p = 0 . 0 0 1 ;I L - 2 ,
130.9 fold, p=0.008; TNFa, 7.4 fold, p=0.001; Wilcoxon Signed
Ranks test; Figure 4).
After dividing the total cytobrush CMC yield into 3 wells for
each treatment, median CMC cell counts after Ficoll separation
were 1.93610
5 (range 5.33610
421.33610
6 cells) per experiment.
There was a positive association between CMC numbers and the
induction of IL-2 gene expression by the HIV epitope pool
(Spearman’s rho =0.879; p,0.001) and by SEB (Spearman’s rho
=0.611; p=0.035). However, no association was observed
between CMC numbers and the induction of either IFNc or
TNFa expression by the HIV epitope pool or SEB (all p$0.1). In
addition, input CMC numbers did not correlate with cervical
HIV-specific or SEB-induced supernatant cytokine levels by
multiplex ELISA (all p.0.4). Therefore, observed IFNc and
TNFa cytokine levels appear to be independent of input cervical
cell numbers.
Discussion
Assay platforms that can reliably quantify HIV-specific cellular
immune responses in the genital tract are urgently needed to
monitor the immunogenicity of candidate HIV vaccines and
elucidate the mucosal immune correlates of HIV transmission and
susceptibility. Inherent limitations in sensitivity, ability to measure
polyfunctional immune responses and low cervical cell yields often
preclude the use of conventional immune assays in this context.
Therefore, we designed a qPCR assay with the goal of measuring
ex vivo HIV-specific cellular T cell responses from cervical
cytobrush specimens. The evaluated qPCR assay was robustly
able to quantify SEB mediated cytokine induction in both CMCs
and PBMCs despite low input cell numbers. However, HIV-
specific cellular T cell responses could only be measured in
PBMCs.
It is unclear why the qPCR assay was unable to detect HIV-
induced cellular T cell responses in cervical cells, particularly in
light of the sensitivity demonstrated at low PBMC input numbers.
Cervical HIV-specific T cell responses have been found to mirror
those present in the blood [8,9,10,26], with a frequency similar to
or greater than those in blood [8] and a common ontogeny [26].
While this is not a universal finding [6], it seems unlikely that a
true discordance in blood-cervical T cell responses would account
for the failure of this QPCR-based technique to detect responses in
all 13 participants studied, particularly given the robust T cell
responses that were seen in PBMC. Instead, an insufficient
sensitivity of the assay to detect responses with this input number
of cervical cells seems more plausible. The lack of measurable
Figure 4. SEB superantigen mRNA cytokine induction in cervical
and blood mononuclear cells from HIV infected participants. (a)
IFNc, (b) TNFa and (c) IL-2 mRNA induction in cervical mononuclear cells
(CMCs) and peripheral blood mononuclear cells (PBMCs) from 13 HIV
infected womenfollowing incubation with superantigen. Horizontallines
representmedianvalues.TheqPCRassay detectedIFNcandIL-2mRNAin
CMCs but not TNFa, while all cytokines were detected in PBMCs.
doi:10.1371/journal.pone.0013077.g004
Figure 5. Correlation of SEB induced IFNc mRNA and protein
induction in cervical cells from HIV infected participants.
Horizontal lines represent median values. IFNc mRNA induction was
associated to IFNc protein production in SEB treated samples.
doi:10.1371/journal.pone.0013077.g005
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also be due to the lower relative proportion of cervical
mononuclear cells that are CD8+ T cells, compared to blood.
Less than 5% of cervical mononuclear cells collected via cytobrush
sampling are actually T cells [9], while blood CD8+ T cell
populations range from 12-23% in HIV infected individuals [27].
The reduced CD8+ T cell proportion may have resulted in
diminished qPCR assay sensitivity regardless of high overall
cytobrush cervical cell yields. In our study total input cell numbers
were counted by trypan blue exclusion on a haemocytometer, and
so we were not able to determine the precise proportion of
mononuclear cells that were CD8+ T cells in either compartment.
This limitation would be better addressed by enumerating T cell
subsets via flow cytometry assays, such as the Guava automated
cell counter [28]. In addition, the use of invasive or pooled samples
from multiple genital sampling techniques, including cervical
biopsies, cervicovaginal lavage or the collection of two or more
cytobrushes may increase yields of cervical mononuclear cells
[8,29]. Lastly, PCR amplification inhibitors in cervical derived
cells have been reported elsewhere [30,31,32], and this may also
have diminished the ability to detect cellular immune responses in
the genital tract via qPCR. However, the identification and impact
of mucosal qPCR inhibitors on measuring cervical cellular
immune responses were not evaluated here and require further
investigation to ascertain their impact.
Despite the lack of HIV-specific immune responses, SEB
induced responses in CMCs were detected by qPCR in most
(but not all) participants, indicating that the assay was functional in
cervical cells. SEB cross-links T cell receptors (TCRs) and MHC
complexes activating both CD4 and CD8 T cells regardless of
antigen specificity [33], unlike the 8-mer HIV epitope pool that
only stimulates HIV-specific CD8+ T cells [34]. The broader
immune activation profile afforded by SEB may therefore facilitate
enhanced detection of mRNA induction at the cervical mucosa. In
addition, the higher affinity constant for SEB-TCR binding and
the mechanism of SEB cross-linking and stabilization of the TCR-
MHC during activation may result in higher avidity for SEB
superantigen binding compared to individual peptide-mediated
MHC-TCR interactions [35]. Consequently, greater T cell
activation may have induced higher cytokine mRNA levels
following stimulation with SEB superantigen relative to HIV
epitope pool stimulation allowing for mRNA detection. However,
the evaluation of superantigen and antigen specific interactions
with TCR is beyond the scope of this report. In a minority of
participants, cervical SEB-induced immune responses were not
always detectable by qPCR. A lack of viable cervical cells would be
one possible explanation, and cell viability was not ascertained in
these experiments. However, SEB-treated cervical cells from both
HIV-infected and uninfected women may sometimes be unre-
sponsive in flow cytometry-based assays despite the demonstration
of cell viability via a live/dead gating strategy (unpublished;
McKinnon L and Kaul R), and so a lack of cell viability is unlikely
to explain these results.
The expression of target gene must be corrected to account for
variation in the quantity and quality of extracted RNA, reverse
transcription and PCR amplification efficiencies and to measure
the relative quantities of target genes[36]. However, the expression
of housekeeping genes also varies under different experimental
conditions [24,36,37]. Therefore we screened a panel of five
commonly used housekeeping genes in CMC and PBMC to
evaluate their stability under different treatment conditions, and
found GAPDH and b-actin genes to be the most stable
housekeeping genes, respectively. Our findings agree with one
[25] but not another [24] of only two prior studies evaluating
qPCR to measure gene expression ex vivo in cervical tissue.
However, these studies were not using qPCR to assay antigen-
specific responses where short-term stimulation might alter the
stability of potential housekeeping genes. For this reason we used
the NormFinder software to directly evaluate intergroup stability
of candidate housekeeping genes in our immunostimulated
samples[37]. In addition, our selected housekeeping genes may
have varied from other reports as our samples were derived from
HIV infected participants. HIV has been demonstrated to exert
substantial effects on the transcription pathways of several classes
of genes [38], including commonly used ‘‘housekeeping genes’’
selected in the above mentioned studies [39]. This study therefore
highlights the importance of selecting a stable reference gene for
normalization of target gene expression based on empirical
evaluation for a given assay condition, cell type and infection
status.
No IL-2 protein was detected in cell culture supernatants using
the cytometric bead array, despite the detection of low-level IL-2
mRNA levels by qPCR. In other studies describing discordance
between mRNA detection and protein synthesis it has been
postulated that a few highly transcriptionally active cells may
permit detection of cytokine mRNA, but that these highly active
cells do not secrete enough protein to be quantified using protein
assays[40]; in this scenario IL-2 protein would be secreted into the
cell supernatant but fall below the lower limit of detection of the
CBA assay (20 pg/ml). Discordant kinetics between mRNA
induction and protein production is another possible explanation.
Finally, since our culture experiments did not block the IL-2-
receptor, any IL-2 produced may have been consumed by
activated immune cells [23,41].
In summary, we describe the process of development and testing
of a real-time quantitative PCR assay to measure ex vivo cervical
HIV-specific cellular T cell responses. We demonstrate an
appropriate algorithm for the selection of housekeeping genes,
and determine the optimal cytokine induction kinetics and cell
input numbers for measuring such responses in the blood.
However, the resulting optimized qPCR assay was not able to
detect HIV-specific cellular T cell responses in the cervix of HIV-
infected women despite similar input cell numbers, and despite the
demonstration of a robust immune response in the PBMCs from
the same participant. The reasons for this result are not clear, but
we believe that the description of the assay development process
will be of use to those in the mucosal vaccine field who are
endeavouring to develop robust platforms to evaluate vaccine-
induced T cell responses in the female genital tract.
Methods
Ethics statement
All participants provided written informed consent, and the
study protocol was reviewed and approved by the Research Ethics
Boards at the University of Nairobi and the University of Toronto.
Sample processing and in vitro antigenic stimulation
Blood samples and cervical cytobrush specimens were obtained
from HIV infected participants in Canada and Kenya who were
not actively menstruating, under research protocols approved by
the Universities of Toronto, Manitoba, and Nairobi as well as The
Kenyatta National Hospital. All HIV-infected participants had a
blood CD4+ T cell count above 350/mm
3, and were antiretroviral
therapy naı ¨ve. Sample collection and processing was performed as
previously described [42]. Briefly, cervical samples were obtained
by first scraping the external cervical os using a plastic cell scraper
(Benzi Jinshuo Applicator Co) and a cervical histobrush (Histo-
qPCR: Assay Cervical Responses
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rotated through 360u. A mini-cervical lavage was then performed
using 1 ml PBS to collect loosened cells. All genital tract samples
were then combined into a 50 ml sample collection tube
containing 10 mls of PBS and transported to the laboratory on
ice within 2 hours. Blood was collected by venipuncture into
heparin Vacutainer tubes (BD Bioscience). Peripheral blood
mononuclear cells (PBMC) and cervical mononuclear cells
(CMCs) were isolated by density gradient centrifugation. Samples
were washed twice and resuspended in RPMI 1640 media with
10% heat inactivated fetal bovine serum, 1% Penicillin and 1%
streptomycin (R10; FBS; Sigma). PBMCs were then used fresh for
stimulation experiments or cryopreserved at 2150uC in FBS
containing 10% DMSO until use. All cervical T cell assays were
performed using freshly obtained cytobrush samples. Both PBMC
and CMC numbers were determined by light microscopy, based
on trypan blue exclusion.
PBMC and CMC samples were incubated with; i) a pool of 49
immunodominant CD8+ optimized HIV epitopes (HIV epitope
pool) restricted by a range of class I HLA alleles, at a concentration
of 2.0 ug/ml/peptide; ii) R10 tissue culture medium alone or
iii) staphylococcal enterotoxin B superantigen (SEB; Sigma) at
3.0 ug/ml. The use of predefined, immunodominant CD8+ HIV
epitopes from multiple HIV clades and restricted by a variety of
different HLA typeswouldallow formeasurementof CD8+ immune
responses in most participants. Kinetics and sensitivity experiments
utilized a variety of input cell numbers and incubation durations (see
results) at 37uCi n5 %C O 2. Cell pellets and supernatants were
harvested by centrifugation at 10,000 rpm for 5 minutes and placed
inRNA later solution (Ambion). Culture supernatants were stored as
is at 280uC prior to qPCR or protein measurements.
RNA extraction
RNA was extracted from cell pellets and genomic DNA was
eliminated using the Qiagen RNAeasy Plus Kit (Qiagen) as per
manufacturer’s instructions. RNA was eluted in 30 ul of nuclease
free water. The quantity of extracted RNA was evaluated using the
Nanodrop ND1000 (Thermofisher Scientific). To ensure the
integrity of RNA, only samples with a 260/280 OD ratio of
between 1.7–2.0 were used.
Reverse Transcription and qPCR
Complementary DNA (cDNA) was created by adding 10 ng of
RNA to the reverse transcription master mix and reverse-
transcribed using the Superscript III Kit (Invitrogen) as per
manufacturer’s instructions. The cDNA product was then diluted
1:7 in nuclease free water and the samples stored at 220uC.
Genomic DNA (gDNA) standards were isolated from purified
placental tissue and used as a universal standard over a 7-log
(36 ng – 0.4 ng) dilution range to calculate relative gene
expression levels [43]. A broad dynamic range of standards was
used to account for the varied expression levels of different
targeted genes. Single intra-exon gene-specific primers were
generated using Primer Express Software (Perkin Elmer Applied
Biosystems). Each primer pair was evaluated for specificity by
melting curve analysis to ascertain that only one product was
amplified and a BLAST search was performed to confirm that
primer sequences amplified only the target gene of interest. Primer
pairs generating multiple peaks (indicative of primer-dimer
artifacts or non-specific gene amplification), or primers with less
than 90% primer-pair amplification efficiency were discarded.
The final primer pairs used are listed in Table 2.
The qPCR assay was performed in a 10 ul volume in a 384-well
plate. ABI Prism 7900HT (Applied Biosystems) and SYBR green
fluorescent dye was used to detect amplification under the
following amplification conditions: i) 1 warm-up cycle for 2 min
at 50uC ii) 1 pre-amplification cycle for 10 minutes at 95uC, 40
amplification cycles for 15 seconds at 95uC and for 1 minute at
60uC, iii) end-amplification cycle for 15 seconds at 95uC, 15
seconds at 60uC and 15 seconds at 95uC. All reactions were run in
triplicate with a non-template control blank) for each primer pair
to control for contamination or primer-dimers. Quantitative PCR
values crossing threshold (Ct) were obtained during the exponen-
tial amplification phase using SDS 2.3 Software (Applied
Biosystems) analysed for respective gene quantities and exported
into Microsoft Excel for further analysis.
Cytokine Protein Quantification
Cytokine concentrations (pg/ml) from culture supernatants
were determined using the flow cytometry based Cytokine Bead
Array Kit (CBA; BD Biosciences) or the Searchlight Multiplex-
ELISA (M-ELISA; Aushon Biosystems) as per manufacturer’s
instructions. Interferon Gamma (IFNc), Tumour Necrosis Factor
alpha (TNFa) and Interleukin 2 (IL-2) cytokines were assayed. The
CBA limit of detection for IFNc, TNFa, IL-2 was 20 pg/ml for all
evaluated analytes while the M-ELISA limit of detection for IFNc,
TNFa, and IL-2 was 0.5, 0.5, 0.1 pg/ml respectively. CBA
samples were run in unicate while M-ELISA samples were assayed
in duplicate. Background (basal) cytokine levels were subtracted
from presented antigen and superantigen specific cytokine levels.
Table 2. Primer sequences for SYBR green Real-Time PCR.
mRNA Target Forward Primer Sequences 59R39 Reverse Primer Sequences 39R59
IFNc AGGGAAGCGAAAAAGGAGTCA GGACAACCATTACTGGGATGCT
TNFa GCCAGAATGCTGCAGGACTT GGCCTAAGGTCCACTTGTGTCA
IL2 ATGAGACAGCAACCATTGTAGAATTT CACTTAATTATCAAGTCAGTGTTGAGATGA
b-Actin TCCCTTGCCATCCTAAAAGCCACCC CTGGGCCATTCTCCTTAGAGAGAAG
TBP GGGCATTATTTGTGCACTGAGA TAGCAGCACGGTATGAGCAACT
GAPDH TGGACCTGACCTGCCGTCTA CCCTGTTGCTGTAGCCAAATTC
B2M GAGTGCTGTCTCCATGTTTGATGT AAGTTGCCAGCCCTCCTAGAG
HPRT GCCTATAGACTATCAGTTCCCTTTGG TGCTGTGGTTTAAGAGAATTTTTTCA
Interferon Gamma (IFNc); Tumour Necrosis Factor alpha (TNFa); Interleukin 2 (IL2); b-2-Microglobulin (B2M); TATA box binding protein (TBP); Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH); Ribosomal Protein L32 (RPL32); human hypoxanthine phosphoribosyltransferase (HPRT).
doi:10.1371/journal.pone.0013077.t002
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Gene quantities were calculated from standard curves in
arbitrary units and values were then analysed using the
NormFinder model within a Microsoft Excel add-on (http://
mdl.dk/publicationsnormfinder.htm). The most stable housekeep-
ing gene was selected to normalize target gene expression levels as
described elsewhere [19]. Briefly, to assess antigen-specific gene
induction, results for each target gene were normalized by dividing
the amount of the amplified gene target by the amount of the
housekeeping gene for each sample. This ratio was then further
divided by the respective negative control (medium alone) at the
given time point, and reported as a Fold gene-induction ratio [19].
Non-parametric Mann-Whitney U and Wilcoxon Signed Ranks
statistical analyses were performed using SPSS Version 17.0
software (SPSS Inc.) to analyse the relationship between gene and
protein expression over different treatments.
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